Edition:
India

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.21USD
14 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.21
Open
$2.19
Day's High
$2.27
Day's Low
$2.17
Volume
10,600
Avg. Vol
401,565
52-wk High
$9.19
52-wk Low
$1.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.002
FY 2018 Dec '18 0.00 -0.002
Sep '18 0.00 -0.002
Jun '18 0.00 -0.005
Mar '18 0.00 -0.001
FY 2017 Dec '17 0.00 -0.008
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-20 2 0.00 0.00 0.00 5.55
Earnings (per share)
Quarter Ending Jun-19 2 -0.18 0.00 -0.36 -0.66
Quarter Ending Sep-19 2 -0.16 0.00 -0.32 -0.86
Year Ending Dec-19 2 -0.60 -0.02 -1.17 -3.42
Year Ending Dec-20 2 -0.39 -0.01 -0.77 -3.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 62.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -18.84 -19.61 19 --
13 Week -45.10 -46.32 13 --
26 Week 26.55 13.97 77 --
52 Week 18.51 14.22 81 --
YTD 42.68 23.89 79 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.88%
# of Holders: 14
Total Shares Held: 931,870
3 Mo. Net Change: 55,105
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.